← Back to Clinical Trials
Recruiting NCT07138768

NCT07138768 Role of MRI in the Early Diagnosis and Management of Acute Stroke and Its Impact on Turnaround Time in Emergency Settings

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07138768
Status Recruiting
Phase
Sponsor Tanta University
Condition Magnetic Resonance Imaging
Study Type OBSERVATIONAL
Enrollment 136 participants
Start Date 2025-08-23
Primary Completion 2026-12-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Magnetic Resonance Imaging

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 136 participants in total. It began in 2025-08-23 with a primary completion date of 2026-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the role of stroke protocol in the early diagnosis and management of acute stroke and its effect on turnaround time (TAT) in emergency settings.

Eligibility Criteria

Inclusion Criteria: * Age ≥18 years. * Both sexes. * Patients with acute stroke who are admitted to the emergency department. Exclusion Criteria: * Contraindications to magnetic resonance imaging (MRI) or computed tomography (CT). * Symptoms strongly suggestive of subarachnoid hemorrhage. * Initiation of antithrombotic or thrombolytic treatment before the completion of both scans. * Inability to complete both scans in time to allow thrombolytic treatment within three h of the onset of symptoms. * Uncontrollable hypertension. * Pregnant or lactating women.

Contact & Investigator

Central Contact

Hend M Mansour, MD

✉ hend.mansour@med.tanta.edu.eg

📞 00201221474344

Frequently Asked Questions

Who can join the NCT07138768 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Magnetic Resonance Imaging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07138768 currently recruiting?

Yes, NCT07138768 is actively recruiting participants. Contact the research team at hend.mansour@med.tanta.edu.eg for enrollment information.

Where is the NCT07138768 trial being conducted?

This trial is being conducted at Tanta, Egypt.

Who is sponsoring the NCT07138768 clinical trial?

NCT07138768 is sponsored by Tanta University. The trial plans to enroll 136 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology